Development and Validation of the Kaiser Permanente Active Surveillance Assessment (KPASA) Calculator

More than 5,700 men with prostate cancer are on active surveillance in KPNC and have their clinical data captured in a templated note. More accurate risk stratification at diagnosis of those destined to be non-progressors would enable better selection for active surveillance. Using pre-exiting data on these men, we will develop and internally validate a risk assessment tool that predicts risk of cancer progression at 1 and 4 years from diagnosis and compare our tool with an existing calculator.

0